Kugwiritsira ntchito Cosdenx kuti Muthandize Psoriatic Arthritis ndi Ankylosing Spondylitis

FDA-Yavomerezedwa kwa Spondyloarthropathies Ena ndi Plaque Psoriasis

Costyx (secukinumab), yopangidwa ndi Novartis, inavomerezedwa ndi FDA pa January 15, 2016 kuti athe kuchiritsidwa ndi akuluakulu omwe ali ndi ankylosing spondylitis ndi achritis yogwira ntchito ya nyamakazi . Anali atavomerezedwa kale mu Januwale 2015 kuti psoriasis ikhale yovuta kwambiri pakati pa anthu akuluakulu omwe akufuna kuti athe kugwiritsa ntchito mankhwalawa. Ankylosing spondylitis ndi psoriatic nyamakazi ndi zotupa za nyamakazi zomwe zimatchedwa spondyloarthropathies .

Chivomerezo cha Costyx chifukwa cha ankylosing spondylitis ndi psoriatic nyamakazi chinachokera ku zotsatira za matenda awiri a ankylosing spondylitis ndi ma psoriatic nyamakazi omwe amachititsa kuti mayesero a katatu akuyendetsedwe ka mankhwala omwe amachititsa kuti azikhala otetezeka. Mayeserowa anali ndi anthu oposa 1,500 omwe anali ndi chimodzi mwa zinthu ziwirizi.

Kodi N'chiyani Chimachititsa Kuti Anthu Azikhala Osangalala?

Nthenda yotchedwa Cosentyx ndi mankhwala omwe amateteza ma chitetezo cha mthupi kuti athetse matenda omwe tatchulawa. Kwenikweni, Cosentyx ndi munthu wotsutsana ndi interleukin-17A (IL-17A) -magulu a anti-monoclonal omwe amamanga IL-17A ndipo amalepheretsana kugwirizana ndi receptor IL-17. Ndi wotsutsana ndi interleukin-17A amene amavomerezedwa kuti athetse matenda osokoneza bongo, psoriatic, ndi psoriasis.

Kodi Mankhwala Amagwiritsidwa Ntchito Motani?

Nthendayi imayendetsedwa ndi jekeseni ya subcutaneous m'matumbo kapena pamimba. Cosdicx imapezeka ngati mankhwala ojambulidwa (150 mg / mL) m'khola limodzi la Sensoready.

Amapezekanso pogwiritsira ntchito kamodzi kamodzi kansalu (150 mg / mL). Pali chivundi chomwe chiyenera kubwezeretsedwanso, koma chomwechi ndi cha akatswiri a zaumoyo okha.

Kwa anthu omwe ali ndi nyamakazi ya psoriatic kapena ankylosing spondylitis, chiwerengero cha Costyx chokhudzidwa chimakhudza mlingo wa 150 mg pa masabata 0, 1, 2, 3 ndi 4, ndipo amatsatira milungu iwiri iliyonse.

Ikhoza kuperekedwanso milungu iwiri iliyonse popanda mlingo wothandizira. Ngati matendawa akugwirabe ntchito, mlingo wa 300 mg ukhoza kuganiziridwa. Kwa psoriasis ya plaque, mlingo woyenera ndi 300 mg pa masabata 0, 1, 2, 3, 4 ndi masabata onse 4 pambuyo pake. Mlingo wapang'ono wa 150 mg ukhoza kukhala wokwanira kwa anthu ena. Kwa anthu omwe ali ndi nyamakazi ya psoriatic ndi psoriasis ya plaque, pulogalamu ya psoriasis yapakiti ikulimbikitsidwa.

Kodi Ndani Sagwiritse Ntchito Zochita Zosasangalatsa?

Anthu amene ayamba kuthamanga kwambiri ndi secukinumab sayenera kugwiritsa ntchito mankhwala.

Zotsatira Zogwirizana

Zotsatira zambiri zomwe zimagwirizanitsidwa ndi zoopsa zowonjezereka zimaphatikizapo nasopharyngitis (zizindikiro zozizira), matenda opuma opuma, ndi kutsekula m'mimba. Zotsatira zina ndizotheka ndipo ngati mukukumana ndi vuto lililonse, funsani dokotala wanu.

Chenjezo ndi Kusamala

Zochenjeza zina ndi zodziletsa zimayanjanitsidwa ndi Cosentyx:

Mawu Ochokera

Monga tikudziwira, mankhwala osokoneza bongo sagwiranso ntchito kwa anthu onse omwe amawayesa. Ndicho chifukwa chake ndikofunikira kukhala ndi njira zambiri zamankhwala. Kuchokera ku Costyx ndi mankhwala oyamba kulumikiza interleukin-17A, njira yamachiritso imapezeka tsopano yomwe inalibepo asanavomereze mankhwala.

Kuti mugwiritse ntchito Costyx mosamala, muyenera kuphunzira momwe mungayankhire bwino, podziwa zotsatira zowopsa ndi machenjezo, ndi kulongosola zochitika zilizonse zovuta zikachitika. Ngati mukufuna kuphunzira zambiri za njirayi, bweretsani kwa dokotala wanu wa zamankhwala. Iye adzakuyendetsani kupita ku chisankho chabwino kwambiri kwa inu.

Zotsatira:

Zambiri. Kufotokozera Information . Novartis Pharmaceuticals Corporation. Revised January 2016.

Zambiri. Malangizo a Mankhwala . Novartis Pharmaceuticals Corporation. Revised January 2016.